secwatch.observer — SEC 8-K summary
======================================

Issuer:     iRhythm Holdings, Inc. (IRTC)
CIK:        0001388658
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0001388658-25-000194
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iRhythm Q2 revenue up 26.1% to $186.7M; net loss narrows to $14.2M; raises FY 2025 guidance
--------------------------------------------------------------------------------

- Revenue $186.7M (+26.1% YoY); gross margin 71.2% (+130 bps).
- Net loss $14.2M ($0.44/sh) improved from $20.1M loss ($0.65/sh) in Q2 2024.
- Adjusted net loss $10.2M ($0.32/sh) improved from $18.8M loss ($0.61/sh) YoY.
- FY 2025 guidance raised: revenue $720M-$730M; adj. EBITDA margin 8.0%-8.5%.
- Unrestricted cash $545.5M; partnership with Lucem Health for AI-driven early disease detection.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388658/000138865825000194/0001388658-25-000194-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388658/000138865825000194/irtc-20250731.htm
  HTML page:      https://secwatch.observer/filing/0001388658-25-000194

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer